Search

Author/Creator Joers, James

1. Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES). (1st December 2022)

Authors:
Pandolfo, Massimo; Reetz, Kathrin; Darling, Alejandra; Rodriguez de Rivera, Francisco Javier; Henry, Pierre-Gilles; Joers, James; Lenglet, Christophe; Adanyeguh, Isaac; Deelchand, Dinesh; Mochel, Fanny; Pousset, Françoise; Pascual, Sílvia; Van den Eede, Delphine; Martin-Ugarte, Itziar; Vilà-Brau,...
Journal:
Neurology
Issue:
Volume 8:Number 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy. Issue 3 (17th December 2019)

Authors:
Kartha, Reena V.; Joers, James; Terluk, Marcia R.; Travis, Abigail; Rudser, Kyle; Tuite, Paul J.; Weinreb, Neal J.; Jarnes, Jeanine R.; Cloyd, James C.; Öz, Gülin
Journal:
Journal of inherited metabolic disease
Issue:
Volume 43:Issue 3(2020)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3. Issue 10 (5th May 2021)

Authors:
Faber, Jennifer; Schaprian, Tamara; Berkan, Koyak; Reetz, Kathrin; França, Marcondes Cavalcante; de Rezende, Thiago Junqueira Ribeiro; Hong, Jiang; Liao, Weihua; van de Warrenburg, Bart; van Gaalen, Judith; Durr, Alexandra; Mochel, Fanny; Giunti, Paola; Garcia‐Moreno, Hector; Schoels, Ludger; Hen...
Journal:
Movement disorders
Issue:
Volume 36:Issue 10(2021)
Page Start:
2273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗